Screener
Jazz Pharmaceuticals JAZZ Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001232524-26-000025
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Purchases of property, plant and equipment | (19.7) | (13.9) |
| Acquisition of investments | (500.0) | (440.1) |
| Acquisition of intangible assets | — | (25.0) |
| Net cash provided by (used in) investing activities | 123.1 | (169.0) |
| Financing activities | ||
| Payment of employee withholding taxes related to share-based awards | (103.6) | (67.2) |
| Repayments of long-term debt | (7.8) | (757.8) |
| Proceeds from employee equity incentive and purchase plans | 32.9 | 11.5 |
Item 1.Financial Statements
FAQ
- What is Jazz Pharmaceuticals's investing cash flow?
- Jazz Pharmaceuticals (JAZZ) reported investing cash flow of $123.1M in Q1 2026.
- How has Jazz Pharmaceuticals's investing cash flow changed year-over-year?
- Jazz Pharmaceuticals's investing cash flow increased by 172.8% year-over-year, from -$169M to $123.1M.
- What is the long-term trend for Jazz Pharmaceuticals's investing cash flow?
- Over 2 years (2021 to 2025), Jazz Pharmaceuticals's investing cash flow has grown at a -46.2% compound annual growth rate (CAGR), from -$5.21B to -$1.51B.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Jazz Pharmaceuticals's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude